Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Acquires BioAnaLab

NEW YORK (GenomeWeb News) – Millipore has acquired Oxford, UK-based BioAnaLab in a bid to expand its biopharmaceutical services offerings into the European market.

The Billerica, Mass.-based life science tools provider did not disclose the purchase price. It said that BioAnaLab's services include assay transfer and development, validation and sample analysis, pharmacokinetics and toxicokinetics, immunogenicity, biological potency, and vaccine services.

Millipore said that it would strengthen BioAnaLab's offerings with its own expertise in biomarker analytical services.

"BioAnaLab will add cGMP support testing capabilities to our portfolio, a solid customer base, and a team of highly talented services professionals with expertise in emerging scientific disciplines," Jonathan DiVincenzo, president of Millipore's Bioscience Division, said in a statement.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.